US Bancorp’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,814
| Closed | -$312K | – | 4253 |
|
|
2021
Q3 | $312K | Buy |
1,814
+87
| +5% | +$15K | ﹤0.01% | 1759 |
|
|
2021
Q2 | $216K | Sell |
1,727
-38
| -2% | -$4.75K | ﹤0.01% | 1940 |
|
|
2021
Q1 | $240K | Buy |
1,765
+58
| +3% | +$7.89K | ﹤0.01% | 1840 |
|
|
2020
Q4 | $218K | Buy |
1,707
+18
| +1% | +$2.3K | ﹤0.01% | 1836 |
|
|
2020
Q3 | $190K | Buy |
1,689
+802
| +90% | +$90.2K | ﹤0.01% | 1786 |
|
|
2020
Q2 | $85K | Buy |
+887
| New | +$85K | ﹤0.01% | 2163 |
|
|
2020
Q1 | – | Sell |
-19
| Closed | -$1K | – | 3788 |
|
|
2019
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 3559 |
|
|
2019
Q3 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 3542 |
|
|
2019
Q2 | – | Sell |
-72
| Closed | -$3K | – | 3716 |
|
|
2019
Q1 | $3K | Buy |
+72
| New | +$3K | ﹤0.01% | 3384 |
|
|
2018
Q3 | – | Sell |
-500
| Closed | -$24K | – | 3736 |
|
|
2018
Q2 | $24K | Hold |
500
| – | – | ﹤0.01% | 2880 |
|
|
2018
Q1 | $20K | Buy |
+500
| New | +$20K | ﹤0.01% | 2947 |
|